Full-year results were in line with expectations, with progress in PSRE and EPM operations reflecting their recovery, with some continuing effects from supply chain disruptions and delays. Booth, HT and ES all showed good growth. Sellafield moved into volume production phase. Medical exited third-party MRI components in favour of the exciting ongoing development of its own technology for a compact helium free MRI system, with planned investment increasing the division’s loss. With Medical invest ....
